175 related articles for article (PubMed ID: 3027850)
1. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results.
Dupont B; Drouhet E
Rev Infect Dis; 1987; 9 Suppl 1():S71-6. PubMed ID: 3027850
[TBL] [Abstract][Full Text] [Related]
2. Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole.
Ganer A; Arathoon E; Stevens DA
Rev Infect Dis; 1987; 9 Suppl 1():S77-86. PubMed ID: 3027851
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to and efficacy of itraconazole in treatment of systemic mycoses: preliminary results.
Phillips P; Fetchick R; Weisman I; Foshee S; Graybill JR
Rev Infect Dis; 1987; 9 Suppl 1():S87-93. PubMed ID: 3027852
[TBL] [Abstract][Full Text] [Related]
4. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
Grant SM; Clissold SP
Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
[TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Van Cutsem J
Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
[TBL] [Abstract][Full Text] [Related]
6. Treatment of invasive aspergillosis with itraconazole.
Denning DW; Tucker RM; Hanson LH; Stevens DA
Am J Med; 1989 Jun; 86(6 Pt 2):791-800. PubMed ID: 2543220
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pulmonary aspergilloma with itraconazole.
Campbell JH; Winter JH; Richardson MD; Shankland GS; Banham SW
Thorax; 1991 Nov; 46(11):839-41. PubMed ID: 1663275
[TBL] [Abstract][Full Text] [Related]
8. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
Wheat J; Hafner R; Wulfsohn M; Spencer P; Squires K; Powderly W; Wong B; Rinaldi M; Saag M; Hamill R; Murphy R; Connolly-Stringfield P; Briggs N; Owens S;
Ann Intern Med; 1993 Apr; 118(8):610-6. PubMed ID: 8383934
[TBL] [Abstract][Full Text] [Related]
9. [In-vitro and in-vivo activity of itraconazole].
Van Cutsem J
Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole in neutropenic patients.
van't Wout JW
Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
[TBL] [Abstract][Full Text] [Related]
11. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Schmitt HJ; Edwards F; Andrade J; Niki Y; Armstrong D
Chemotherapy; 1992; 38(2):118-26. PubMed ID: 1317280
[TBL] [Abstract][Full Text] [Related]
12. Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
Moore L; Ellis DH; Suppiah R; Byard RW; Toogood IR
J Paediatr Child Health; 1993 Apr; 29(2):141-3. PubMed ID: 8387801
[TBL] [Abstract][Full Text] [Related]
13. Tropical mycoses.
Bayles MA
Chemotherapy; 1992; 38 Suppl 1():27-34. PubMed ID: 1319312
[TBL] [Abstract][Full Text] [Related]
14. European experience with itraconazole in systemic mycoses.
Viviani MA; Tortorano AM; Pagano A; Vigevani GM; Gubertini G; Cristina S; Assaisso ML; Suter F; Farina C; Minetti B
J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):587-93. PubMed ID: 2170478
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Longman LP; Martin MV
J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P
Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole, a new triazole that is orally active in aspergillosis.
Van Cutsem J; Van Gerven F; Van de Ven MA; Borgers M; Janssen PA
Antimicrob Agents Chemother; 1984 Oct; 26(4):527-34. PubMed ID: 6097167
[TBL] [Abstract][Full Text] [Related]
18. [The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections].
Uchida K; Yamaguchi H; Shibuya K
Jpn J Antibiot; 1991 May; 44(5):588-99. PubMed ID: 1652657
[TBL] [Abstract][Full Text] [Related]
19. [Mycoses as opportunistic infections in AIDS patients].
Viviani MA
Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
[TBL] [Abstract][Full Text] [Related]
20. Itraconazole therapy in aspergillosis: study in 49 patients.
Dupont B
J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):607-14. PubMed ID: 2170481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
